With its trials and pricing set, Pfizer has pulled back the curtain on the long-range commercial strategy for its COVID-19 vaccine. During its earnings call Tuesday, execs laid out two phases, pandemic and seasonal, with some combination of the two likely to play out over the next several years. The current pandemic phase, expected to continue… Read More »
On the heels of early positive COVID-19 vaccine data, the CEOs at BioNTech and Pfizer are gearing up for a late-stage trial and talking up potential approvals later this year. In separate interviews this week, Pfizer CEO Albert Bourla and BioNTech CEO Ugur Sahin said their mRNA vaccine candidate could be ready to submit to regulators in the fall or winter, respectively, pending success in… Read More »
Pharma companies including Pfizer, Novartis and AbbVie have paused advertising on Facebook for July. Their brands join others in the Stop Hate for Profit campaign, meant to pressure Facebook into taking action against hate and disinformation spread on its platform. Pfizer is the largest of the pharma companies participating and one of three overall top 25… Read More »